HIV-1 p17 Protein

Produktnummer ABIN934425

Dieses Recombinant HIV-1 p17-Protein wird in Escherichia coli (E. coli) exprimiert.

Kurzübersicht für HIV-1 p17 Protein (ABIN934425)

Target: HIV-1 p17 (Human Immunodeficiency Virus 1 Matrix (HIV-1 p17))

Protein-Typ: Recombinant

Spezies: Human Immunodeficiency Virus (HIV)

Quelle: Escherichia coli (E. coli)

Reinheit: > 90 % pure

Produktdetails

Produktmerkmale: Purified recombinant HIV1 p17 protein
Expression System: E.coli

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Buffer: Lyophilized from 150 mM NaCl, 50 mM citrate sodium, pH 6.5, no preservatives.

Konservierungsmittel: Without preservative

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C until reconstitution. Following reconstitution aliquot and freeze at -70 °C for long term storage.

Antigendetails

Target: HIV-1 p17 (Human Immunodeficiency Virus 1 Matrix (HIV-1 p17))

Andere Bezeichnung: HIV1 p17

Substanzklasse: Viral Protein

Hintergrund: HIV1 p17 is the matrix protein of the Gag polyprotein which performs highly complex tasks during the assembly, budding, maturation, and infection stages of the viral replication cycle. During viral assembly, the proteins form membrane associations and self-associations that ultimately result in budding of an immature virion from the infected cell. Gag precursors also function during viral assembly to selectively bind and package two plus strands of genomic RNA. .
Alternative Names: HIV1 p17, HIV 1 p17 protein, HIV 1 p17 protein, HIV-1 p17 protein, HIV-1 p17, Human Immunodeficiency Virus 1 protein, HIV 1 p17, HIV1 matrix protein p17 protein, Matrix protein p17 protein, HIV-1 p17 protein, MA protein, p17 protein